Myrexis Inc (MYRX.PK)
MYRX.PK on OTC Markets Group
0.07USD
1 Aug 2013
0.07USD
1 Aug 2013
Price Change (% chg)
$0.00 (+4.33%)
$0.00 (+4.33%)
Prev Close
$0.07
$0.07
Open
$0.07
$0.07
Day's High
$0.07
$0.07
Day's Low
$0.07
$0.07
Volume
26,691
26,691
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
About
Myrexis Inc, is a biopharmaceutical company that has generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. The Company retains all rights to all of its drug candidates and programs across all geographic markets and therapeutic indications. In February 2012, the Company suspended development... (more)
No analyst recommendations are available for MYRX.PK.
Overall
| Beta: | 0.95 |
| Market Cap (Mil.): | $2.31 |
| Shares Outstanding (Mil.): | 34.48 |
| Dividend: | 2.86 |
| Yield (%): | -- |
Financials
| MYRX.PK | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 38.06 | 37.87 |
| EPS (TTM): | -0.42 | -- | -- |
| ROI: | -25.67 | 19.42 | 18.70 |
| ROE: | -25.67 | 20.10 | 19.53 |
Competitors
| Price | Change | |
|---|---|---|
| Novartis AG (NOVN.VX) | CHF67.55 | +0.95 |
| Sanofi SA (SASY.PA) | €76.36 | -0.49 |
| AstraZeneca plc (AZN.L) | 3,332.50p | -1.50 |
| Merck KGaA (MRCG.DE) | €126.60 | -0.55 |
| Bristol Myers Squibb Co. (BMY.N) | $43.85 | -0.14 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Pfizer Inc. (PFE.N) | $29.32 | +0.21 |
| Biogen Idec Inc (BIIB.OQ) | $226.78 | +6.56 |
| Gilead Sciences, Inc. (GILD.OQ) | $61.43 | -0.57 |
| Vernalis plc (VER.L) | 22.50p | -0.62 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$368.00
|
|
Provider: Jefferson Research
|
$127.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

